Hey there, it’s Brandon.
Pull a thousand traders today and ask them what's on their radar for next week.
They'll tell you about Tesla earnings, Fed announcements, maybe some AI stock making headlines. You know what they won't mention?
ELDN.
Never heard of it? Neither had most people until the Ghost Prints Console lit up this morning.
Here's what caught my eye: Eledon Pharmaceuticals typically trades around 64 call contracts on an average day. Nothing special, right? Just another small biotech floating under the radar.
Today? Nearly 5,000 call contracts traded.
Someone bought over 2,000 contracts for November 21st expiration at the $7.50 strike.
I don't know about you, but who buys 2,000 call contracts on a stock most retail traders have never heard of? This isn't some Reddit crowd piling in. This is institutional money making a calculated bet.
Why November 21st? Why $7.50? Why Now?
November 7th, 8:00 AM ET - Eledon presents Phase 2 BESTOW trial results at the American Society of Nephrology's Kidney Week. We're talking about their lead drug candidate for kidney transplant patients.
November 11th - Q3 earnings report.
Someone just dropped serious money on calls expiring November 21st - giving them a two-week window to capture moves from BOTH catalysts.
This Is Why Your Scanner Isn't Working
Your typical scanner shows you ELDN move on trial results. By then, you're chasing. By then, you're late.
The Ghost Prints Console flagged this institutional footprint BEFORE the catalyst hits the tape.
The Pressure Building Beneath the Surface
Here's what happens next: The options market makers who sold those 2,000 calls have to hedge. As ELDN approaches $7.50, they're buying stock. Push through $7.50 with positive catalyst news, and you've got structural buying pressure.
Pressure builds silently, then releases explosively.
It's the same principle behind every squeeze play we've caught - Kohl's up 135%, Rocket up 22%, Beyond Meat up 1000%.
What's Your Next Move?
November 7th is six days away. Someone with deep pockets just made a bet worth watching. You now have the same information they used to make their decision.
That's the difference between trading blind and trading with institutional intelligence.
The question isn't whether ELDN hits $7.50 by November 21st. The question is: Do you want to see these setups as they're forming, or keep reacting after the smart money already moved?
By the time ELDN shows up on your screeners, someone already made their decision six days ago.
Join Ghost Prints today and get the same surveillance console that flagged this ELDN trade - plus every other institutional footprint hitting the market.
Click here to lock in your access before we split the console into a separate $4,995 product.
Stay Sharp,
Brandon Chapman